Bladder Cancer Diagnostic Market Research: Key Insights

Brief:

Market research study for a bladder cancer diagnostic device

Countries:

US

Methodology:

Qualitative and quantitative: urologists and urology oncologists

The research explored:

Working with practising urologists and oncologists across key markets, we explored current diagnostic and surveillance pathways for bladder cancer — including cystoscopy utilisation, biomarker testing, and the role of emerging non-invasive diagnostics — to assess the clinical and commercial opportunity for a novel detection device

Delivered:

Detailed analysis of the bladder cancer diagnostic landscape, drivers of current device and test selection, attitudinal segmentation of target physicians, unmet needs in detection and recurrence monitoring, barriers to adoption of novel diagnostics, and a triangulated market sizing based on incidence data, procedure volumes, and stated physician intent